help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groop, L. C.
Right arrow Articles by DeFronzo, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groop, L. C.
Right arrow Articles by DeFronzo, R. A.

Journal of Clinical Endocrinology & Metabolism, Vol 72, 96-107, Copyright © 1991 by Endocrine Society


ARTICLES

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

LC Groop, C Saloranta, M Shank, RC Bonadonna, E Ferrannini and RA DeFronzo
Fourth Department of Medicine, Helsinki University Hospital, Finland.

To investigate the mechanisms of insulin resistance in obesity and noninsulin-dependent diabetes mellitus (NIDDM), we examined oxidative and nonoxidative pathways of free fatty acid (FFA) and glucose metabolism in 14 lean and 17 obese (with normal oral glucose tolerance) nondiabetic subjects and in 8 lean and 8 obese subjects with NIDDM. FFA and glucose metabolism were measured using the sequential insulin clamp technique in combination with indirect calorimetry and infusion of [3- 3H]glucose and [1-14C]palmitate. Obesity was characterized by enlarged fat mass, which correlated positively with the plasma FFA concentration (r = 0.62; P less than 0.01). FFA metabolism was less sensitive to insulin in obese than in lean nondiabetic subjects, but this defect could be overcome by increasing the plasma insulin concentration. NIDDM patients showed normal sensitivity to the inhibitory action of insulin on FFA metabolism; however, maximal suppression by insulin was impaired. The combination of obesity and NIDDM was associated with a further enhancement of reesterification of FFA than observed in either condition alone. In both obesity and NIDDM, the dose-response curve for suppression of hepatic glucose production by insulin was impaired. While obesity was primarily characterized by reduced sensitivity to the stimulatory action of insulin on oxidative and nonoxidative pathways of glucose metabolism, resistance to the effect of insulin on glucose metabolism in NIDDM was characterized by a reduced maximal response. The combination of obesity and NIDDM further impaired the sensitivity of liver glucose output and glucose oxidation to insulin. The hypothesis is advanced that in uncomplicated obesity, increased availability and oxidation of FFA leads, by the FFA/glucose cycle, to the impairment in glucose utilization. In NIDDM, on the other hand, the defect in glucose utilization is primary, and the enhanced rate of FFA oxidation may represent a compensatory phenomenon.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
K. D. Monahan, D. J. Dyckman, and C. A. Ray
Effect of acute hyperlipidemia on autonomic and cardiovascular control in humans
J Appl Physiol, July 1, 2007; 103(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. L. Wang, L. Zhang, K. Youker, M.-X. Zhang, J. Wang, S. A. LeMaire, J. S. Coselli, and Y. H. Shen
Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase.
Diabetes, August 1, 2006; 55(8): 2301 - 2310.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. H. Claus, D. B. Lowe, Y. Liang, A. I. Salhanick, C. K. Lubeski, L. Yang, L. Lemoine, J. Zhu, and K. B. Clairmont
Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Bajaj, S. Suraamornkul, A. Romanelli, G. W. Cline, L. J. Mandarino, G. I. Shulman, and R. A. DeFronzo
Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients
Diabetes, November 1, 2005; 54(11): 3148 - 3153.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Belfort, L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, R. Berria, R. A. DeFronzo, and K. Cusi
Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Diabetes, June 1, 2005; 54(6): 1640 - 1648.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Giannopoulou, L. L. Ploutz-Snyder, R. Carhart, R. S. Weinstock, B. Fernhall, S. Goulopoulou, and J. A. Kanaley
Exercise Is Required for Visceral Fat Loss in Postmenopausal Women with Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Alemzadeh and K. M. Tushaus
Modulation of Adipoinsular Axis in Prediabetic Zucker Diabetic Fatty Rats by Diazoxide
Endocrinology, December 1, 2004; 145(12): 5476 - 5484.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Bajaj, S. Suraamornkul, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo
Sustained Reduction in Plasma Free Fatty Acid Concentration Improves Insulin Action without Altering Plasma Adipocytokine Levels in Subjects with Strong Family History of Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4649 - 4655.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R. A. DeFronzo
Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3914 - 3921.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Faraj and K. Cianflone
Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E150 - E159.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Bays, L. Mandarino, and R. A. DeFronzo
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 463 - 478.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Zhang, D. I. W. Phillips, C. Wang, and C. D. Byrne
Human skeletal muscle PPAR{alpha} expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E168 - E175.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Huang, A. Vaag, E. Carlsson, M. Hansson, B. Ahren, and L. Groop
Impaired Cathepsin L Gene Expression in Skeletal Muscle Is Associated With Type 2 Diabetes
Diabetes, September 1, 2003; 52(9): 2411 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E.-J. Freyse, T. Giessmann, K. J. Petzke, S. Knospe, G. Engel, P. Heinke, C. C. Metges, and W. Siegmund
Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E54 - E62.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Bajaj, S. Suraamornkul, T. Pratipanawatr, L. J. Hardies, W. Pratipanawatr, L. Glass, E. Cersosimo, Y. Miyazaki, and R. A. DeFronzo
Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes
Diabetes, June 1, 2003; 52(6): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Tiikkainen, R. Bergholm, S. Vehkavaara, A. Rissanen, A.-M. Hakkinen, M. Tamminen, K. Teramo, and H. Yki-Jarvinen
Effects of Identical Weight Loss on Body Composition and Features of Insulin Resistance in Obese Women With High and Low Liver Fat Content
Diabetes, March 1, 2003; 52(3): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. H. Clerk, M. E. Smith, S. Rattigan, and M. G. Clark
Nonnutritive flow impairs uptake of fatty acid by white muscles of the perfused rat hindlimb
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E611 - E617.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza
Elevated Free Fatty Acids Impair Glucose Metabolism in Women: Decreased Stimulation of Muscle Glucose Uptake and Suppression of Splanchnic Glucose Production During Combined Hyperinsulinemia and Hyperglycemia
Diabetes, January 1, 2003; 52(1): 38 - 42.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Bajaj, T. Pratipanawatr, R. Berria, W. Pratipanawatr, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free Fatty Acids Reduce Splanchnic and Peripheral Glucose Uptake in Patients With Type 2 Diabetes
Diabetes, October 1, 2002; 51(10): 3043 - 3048.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Cnop, J. C. Hannaert, A. Y. Grupping, and D. G. Pipeleers
Low Density Lipoprotein Can Cause Death of Islet {beta}-Cells by Its Cellular Uptake and Oxidative Modification
Endocrinology, September 1, 2002; 143(9): 3449 - 3453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Bajaj, R. Berria, T. Pratipanawatr, S. Kashyap, W. Pratipanawatr, R. Belfort, K. Cusi, L. Mandarino, and R. A. DeFronzo
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E346 - E352.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. G. McTernan, A. L. Harte, L. A. Anderson, A. Green, S. A. Smith, J. C. Holder, A. H. Barnett, M. C. Eggo, and S. Kumar
Insulin and Rosiglitazone Regulation of Lipolysis and Lipogenesis in Human Adipose Tissue In Vitro
Diabetes, May 1, 2002; 51(5): 1493 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Pratipanawatr, K. Cusi, P. Ngo, W. Pratipanawatr, L. J. Mandarino, and R. A. DeFronzo
Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes
Diabetes, February 1, 2002; 51(2): 462 - 468.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Segerlantz, M. Bramnert, P. Manhem, E. Laurila, and L. C. Groop
Inhibition of the Rise in FFA by Acipimox Partially Prevents GH-Induced Insulin Resistance in GH-Deficient Adults
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5813 - 5818.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. M. Sandqvist, J. W. Eriksson, and P.-A. E. Jansson
Increased Lactate Release per Fat Cell in Normoglycemic First-Degree Relatives of Individuals With Type 2 Diabetes
Diabetes, October 1, 2001; 50(10): 2344 - 2348.
[Abstract] [Full Text]


Home page
JAMAHome page
A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
JAMA, July 18, 2001; 286(3): 327 - 334.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Staehr, O. Hother-Nielsen, K. Levin, J. J. Holst, and H. Beck-Nielsen
Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients
Diabetes, June 1, 2001; 50(6): 1363 - 1370.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Basu, R. Basu, P. Shah, A. Vella, R. A. Rizza, and M. D. Jensen
Systemic and regional free fatty acid metabolism in type 2 diabetes
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E1000 - E1006.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. E. Kelley and B. H. Goodpaster
Skeletal Muscle Triglyceride: An aspect of regional adiposity and insulin resistance
Diabetes Care, May 1, 2001; 24(5): 933 - 941.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Rendell, U. L. Hulthén, C. Törnquist, L. Groop, and I. Mattiasson
Relationship between Abdominal Fat Compartments and Glucose and Lipid Metabolism in Early Postmenopausal Women
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 744 - 749.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Carlsson, Y. Wessman, P. Almgren, and L. Groop
High Levels of Nonesterified Fatty Acids Are Associated With Increased Familial Risk of Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1588 - 1594.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Vigili de Kreutzenberg, C. Crepaldi, S. Marchetto, L. Calò, A. Tiengo, S. Del Prato, and A. Avogaro
Plasma Free Fatty Acids and Endothelium-Dependent Vasodilation: Effect of Chain-Length and Cyclooxygenase Inhibition
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 793 - 798.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
M. Cnop, A. Grupping, A. Hoorens, L. Bouwens, M. Pipeleers-Marichal, and D. Pipeleers
Endocytosis of Low-Density Lipoprotein by Human Pancreatic {beta} Cells and Uptake in Lipid-Storing Vesicles, Which Increase with Age
Am. J. Pathol., January 1, 2000; 156(1): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. B. Albu, M. Curi, M. Shur, L. Murphy, D. E. Matthews, and F. X. Pi-Sunyer
Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E551 - E560.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. RUPP
Excess Catecholamine Syndrome: Pathophysiology and Therapy
Ann. N.Y. Acad. Sci., June 21, 1999; 881(1): 430 - 444.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. B. Ruderman, A. K. Saha, D. Vavvas, and L. A. Witters
Malonyl-CoA, fuel sensing, and insulin resistance
Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E1 - E18.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Karjalainen, J. Pihlajamaki, P. Karhapaa, and M. Laakso
Impaired Insulin-Stimulated Glucose Oxidation and Free Fatty Acid Suppression in Patients with Familial Combined Hyperlipidemia : A Precursor Defect for Dyslipidemia?
Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1548 - 1553.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Toft, K. H. Bonaa, and T. Jenssen
Insulin Resistance in Hypertension Is Associated With Body Fat Rather Than Blood Pressure
Hypertension, July 1, 1998; 32(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. T. Stepniakowski, G. Lu, G. D. Miller, and B. M. Egan
Fatty Acids, Not Insulin, Modulate {alpha}1-Adrenergic Reactivity in Dorsal Hand Veins
Hypertension, November 1, 1997; 30(5): 1150 - 1155.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Koyama, G. Chen, Y. Lee, and R. H. Unger
Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E708 - E713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. D. Berk, S.-L. Zhou, C.-L. Kiang, D. Stump, M. Bradbury, and L. M. Isola
Uptake of Long Chain Free Fatty Acids Is Selectively Up-regulated in Adipocytes of Zucker Rats with Genetic Obesity and Non-insulin-dependent Diabetes Mellitus
J. Biol. Chem., March 28, 1997; 272(13): 8830 - 8835.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Chen, K. Koyama, X. Yuan, Y. Lee, Y.-T. Zhou, R. O'Doherty, C. B. Newgard, and R. H. Unger
Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy
PNAS, December 10, 1996; 93(25): 14795 - 14799.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society